Sort
64,565 grants matching “drug discovery”
HBV Capsid Effectors
$702,799Raymond F. Schinazi · Emory University · R01 · FY2023 · AI
HBV Capsid Effectors
$702,799Raymond F. Schinazi · Emory University · R01 · FY2025 · AI
Molecular Dynamics and Artificial Intelligence Based Tools to Innovate Covalent and Noncovalent Drug Design
$702,792Julie Anne Harris · Computchem Llc · R44 · FY2021 · GM
PrEP uptake/adherence to reduce periconception HIV risk for South African women
$702,506Lynn T Matthews · Massachusetts General Hospital · R01 · FY2016 · MH
Clinical Informatics to Advance Epidemiology and Pharmacogenetics of Serious Cutaneous Adverse Drug Reactions
$702,476Li Zhou · Brigham And Women'S Hospital · R01 · FY2022 · AI
Neurotensin receptor 1 as a novel target for opioid use disorder and discovery of new small molecule probes
$702,476Lauren M Slosky · University Of Minnesota · R01 · FY2025 · DA
Origin of Cortical Species-specific Distinctions.
$702,403Pasko Rakic · Yale University · R01 · FY2015 · DA
(-)-Phenserine inhibition of neuronal death in Alzheimer's disease and developing brain-labeled plasma exosomes assays as biomarkers for a phenserine phase 1b ascending dose trial
$702,380Lon S Schneider · University Of Southern California · R01 · FY2020 · AG
Role of SCN1B in Inherited Epilepsy
$702,340Lori L Isom · University Of Michigan At Ann Arbor · R37 · FY2017 · NS
Lung cancer oncogenotype-selective drug target discovery
$702,338Michael G Roth · Ut Southwestern Medical Center · U01 · FY2013 · CA
Lead optimization and target identification of drugs targeting hypnozoites
$702,238Dennis E Kyle · University Of Georgia · R01 · FY2020 · AI
High-Throughput BioMEMS
$702,204Daniel J Ehrlich · Boston University (Charles River Campus) · R01 · FY2012 · HG
Characterizing Vancomycin-Resistant C. difficile Strains at Two Geographically Distinct Locations
$702,187Charles Darkoh · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · AI
Skeletal Muscle Molecular Drug Targets for Exercise-induced Cardiometabolic Health
$702,079William E Kraus · Duke University · R01 · FY2023 · HL
Targeting RIPK3 in Flu-Associated Lung Injury
$702,005Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2023 · AI
PRECLINICAL MEDICATIONS DISCOVERY & ABUSE LIABILITY TESTING FOR NIDA
$702,004Louis S. Harris · Virginia Commonwealth University · N01 · FY2012 · DA
Biological Comparisons Among Three Derivative Models of Glioma Patient Cancers Under Microenvironmental Stress
$702,000Christopher D Willey · University Of Alabama At Birmingham · U01 · FY2022 · CA
Development and Prevention of Substance Abuse Problems
$702,000Kenneth A Dodge · Duke University · R01 · FY2009 · DA
Regulatory landscape of the human genome: comparative and evolutionary analysis.
$701,933Ivan Ovcharenko · National Library Of Medicine · ZIA · FY2016 · LM
MRI-GENetics Interface Exploration_MRI-GENIE_Study
$701,927Natalia S Rost · Massachusetts General Hospital · R01 · FY2015 · NS
CELL WALL OF M TUBERCULOSIS: FOCUS FOR DRUG DISCOVERY
$701,902Colorado State University-Fort Collins · P01 · FY2000 · AI
Contribution of Stress Induced Autonomic and Urothelial Dysregulation to IC/BPS
$701,858Lori A Birder · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DK
Complex Human Diseases - From Gene to Function to Therapy
$701,821Michael Dean · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Novel approaches to monitoring and utilizing adherence to HIV therapy in Africa
$701,794David Roy Bangsberg · Massachusetts General Hospital · R01 · FY2011 · MH
Developing Cyclopeptide Nef Inhibitors to Facilitate HIV-1 Eradication
$701,761Xiaofei Jia · University Of Massachusetts Dartmouth · R01 · FY2023 · AI